Magnolia: benefits, dosage, contraindications

Anxiolytic

The bark of Magnolia officinalis has been utilized in traditional Chinese medicine to treat various mental disorders including anxiety. Researchers have focused their efforts on demonstrating the antidepressant, anxiolytic, and sedative effects of decoctions containing Magnolia. The GABA system plays a crucial role in our brain by regulating our responses to stress and anxiety. Honokiol and dihydrohonokiol, two natural compounds of Magnolia, exhibit anxiolytic effects in animals by interacting with gamma-aminobutyric acid A (GABA-A) receptors and muscarinic receptors. A study also explored the effects of dihydrohonokiol-B, a cousin of honokiol, which, when combined with anxiolytic medications like diazepam, shows enhanced efficacy. This synergy suggests that Magnolia could potentially enhance the effects of conventional anxiety treatments. Additionally, Magnolia extracts have shown an affinity for adenosine A(1) receptors, a type of receptor in the brain that plays a role in sleep regulation and anxiety, which is consistent with traditional anxiolytic activities.

Usages associés

Antibacterial

Honokiol and magnolol have marked antimicrobial effects against: - Actinobacillus actinomycetemcomitans, a bacillus part of the human oral flora involved in periodontal diseases. - Porphyromonas gingivalis, a bacterial species present in the oral cavity, responsible for gingivitis and potentially promoting Alzheimer's disease through the release of toxic proteins. - Prevotella intermedia, a pathogenic bacterium involved in periodontal infections, including gingivitis and periodontitis. - Micrococcus luteus, a soil, dust, water, and air bacterium part of the natural skin flora and can also colonize the mouth, mucous membranes, particularly the oropharynx and upper human respiratory tract. They were NOT active against Shigella flexneii, Staphylococcus epidermidis, Enterobacter aerogenes, Proteus vulgaris, Escherichia coli, and Pseudomonas aeruginosa. An extract of bark and magnolol inhibited the growth of Helicobacter pylori, a bacterium responsible for gastric ulcers, in an in vitro study.

Usages associés

Neurological

Research suggests that magnolol and honokiol could play a key role in enhancing cholinergic function, essential for memory and learning. They promote the increase of acetylcholine, a vital neurotransmitter, particularly in the hippocampus, the brain region associated with memory formation. This action could be beneficial in the context of Alzheimer's disease, where neuronal communication is often compromised. In addition to increasing acetylcholine, these compounds also nourish neurons (neurotrophic effect), promoting healthy neuronal function. Their antioxidant effect reduces reactive oxygen species and reinforces their neuroprotective properties. Research has shown that Magnolia can also intervene in decreasing the levels of beta-amyloid peptide, a component associated with the progression of Alzheimer's disease, and protect against the cell death it induces.

Usages associés

Antiallergic

Magnolia contains a compound called magnone. This is particularly interesting against allergic symptoms such as nasal congestion and rhinitis. Its action is based on its ability to counter the activity of platelet-activating factor, a crucial element in the body's allergic and inflammatory reactions. In terms of asthma treatment, magnolia is promising by intervening in cortisol metabolism. It inhibits the enzyme responsible for the conversion of cortisol to cortisone, which increases the availability of corticosteroid, a glucocorticoid similar to cortisol and useful in asthma management. The magnolol and honokiol compounds, also present in magnolia, offer dual action: they relax airways by acting as calcium antagonists and reduce type IV allergic reactions, mediated by T lymphocytes. Additionally, the alkaloids in magnolia act against contractions induced by acetylcholine, providing an additional pathway by which magnolia can assist in asthma treatment.

Usages associés

Anticancer

Laboratory studies show that magnolol, a compound of magnolia, may have beneficial effects against leukemia. This action is due to its ability to intervene in various cellular signaling pathways, which are crucial in cancer development and progression. Magnolol and honokiol regulate the expression of certain genes and promote apoptosis; the programmed process of cell death. This mechanism is particularly important as it allows for the controlled elimination of cancerous cells. Moreover, obovotol, as well as some alkaloids present in magnolia, also contribute to these anticancer effects. These substances could enhance magnolia's antitumor action by targeting different stages and mechanisms involved in cancer cell growth and survival.

Anti-inflammatory

The lignans of magnolia, particularly magnolol and honokiol, play a key role in modulating inflammatory responses. They can downregulate the activation of the nuclear factor-kappa B (NF-κB), a central element in controlling the gene transcription of inflammatory responses. By blocking NF-κB activation, magnolol and honokiol help reduce the expression of genes involved in pro-inflammatory processes. Furthermore, these lignans interfere with the formation of eicosanoids, important signaling molecules in inflammatory and immune processes. They inhibit the production of prostaglandin E2 and thromboxane B2, two notable eicosanoids. This is likely due to the inhibitory effect of magnolol and honokiol on key enzymes like phospholipase A2 and cyclooxygenase, involved in the synthesis of eicosanoids.

Usages associés

Digestive Effect

Magnolia is an antispasmodic that works by relaxing the smooth muscles of the digestive tract. Both magnolol and honokiol are non-competitive muscarinic antagonists and inhibit contractions induced by acetylcholine, serotonin, or calcium-dependent contractions induced by acetylcholine. Moreover, magnolia extracts have anti-gastric ulcer activity. Indeed, intragastric administration of an aqueous and methanolic magnolia extract (400 mg/kg) reduced gastric juice secretion and increased the pH of gastric secretions in mice pretreated with indomethacin.

Antioxidant

When absorbed by the body, honokiol exhibits significant antioxidant properties, particularly effective against hydroxyl radicals. These radicals are reactive oxygen species known for their potential to cause cellular damage. The antioxidant effectiveness of honokiol is attributed to the presence of allyl groups in its chemical structure. These allyl groups allow for more effective interaction with free radicals, neutralizing their harmful activity. Comparatively, honokiol presents a superior antioxidant capability to that of magnolol, another compound from magnolia. This difference is explained primarily by the higher activity of the allylic groups in honokiol, which enhance its power to neutralize free radicals.

Antidepressant

In animals, a mixture of honokiol and magnolol with ginger rhizome creates a synergistic antidepressant action by regulating serotonergic functions and gastrointestinal system functions. Indeed, the mixture of honokiol and magnolol increased serotonin levels in various brain regions, and ginger rhizome reduced cholecystokinin levels in gastric mucosa and serum gastrin in rats.

Usages associés

Cardiovascular

The positive effects of magnolia on atherosclerosis are attributed to the antioxidant activities of magnolol and honokiol. Laboratory research suggests that honokiol decreases the expression of inducible nitric oxide synthase, the generation of reactive oxygen species, intracellular calcium accumulation, and mitigates the effects of oxidized low-density lipoprotein. Magnolol also interferes with the generation of reactive oxygen species.